Recent major advances in cardiovascular pharmacotherapy

被引：0
|
作者：
James Milner
Andreia Cunha
Carlota Gamboa-Cruz
Julie Reis
Márcia Campos
Natália António
机构：
[1] Coimbra Hospital and Universitary Centre,Cardiology Department
[2] University of Coimbra,Institute of Pharmacology and Therapeutics, Faculty of Medicine
来源：
European Journal of Clinical Pharmacology | 2018年 / 74卷
关键词：
Cardiovascular drugs; Systolic heart failure; Coronary artery disease; Hypercholesterolemia; Anticoagulation agents; Antidotes;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
The field of cardiovascular pharmacotherapy remains extremely active. The aim of this review is to summarize the recent major advances in cardiovascular pharmacotherapy, with a focus on (1) the new approved drug for treatment of heart failure with reduced ejection fraction—sacubitril/valsartan; (2) proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors; (3) the novel reversal agents for non-vitamin K oral anticoagulants (NOACs); and finally, (4) new evidence on pharmacological treatment of coronary artery disease.
引用
收藏
页码：853 / 862
页数：9
相关论文
共 50 条
12345